281 related articles for article (PubMed ID: 21085606)
1. Functional interaction between acyl-CoA synthetase 4, lipooxygenases and cyclooxygenase-2 in the aggressive phenotype of breast cancer cells.
Maloberti PM; Duarte AB; Orlando UD; Pasqualini ME; Solano AR; López-Otín C; Podestá EJ
PLoS One; 2010 Nov; 5(11):e15540. PubMed ID: 21085606
[TBL] [Abstract][Full Text] [Related]
2. The functional interaction between Acyl-CoA synthetase 4, 5-lipooxygenase and cyclooxygenase-2 controls tumor growth: a novel therapeutic target.
Orlando UD; Garona J; Ripoll GV; Maloberti PM; Solano ÁR; Avagnina A; Gomez DE; Alonso DF; Podestá EJ
PLoS One; 2012; 7(7):e40794. PubMed ID: 22808264
[TBL] [Abstract][Full Text] [Related]
3. Acyl-CoA synthetase-4 is implicated in drug resistance in breast cancer cell lines involving the regulation of energy-dependent transporter expression.
Orlando UD; Castillo AF; Medrano MAR; Solano AR; Maloberti PM; Podesta EJ
Biochem Pharmacol; 2019 Jan; 159():52-63. PubMed ID: 30414939
[TBL] [Abstract][Full Text] [Related]
4. Acyl-CoA synthetase-4, a new regulator of mTOR and a potential therapeutic target for enhanced estrogen receptor function in receptor-positive and -negative breast cancer.
Orlando UD; Castillo AF; Dattilo MA; Solano AR; Maloberti PM; Podesta EJ
Oncotarget; 2015 Dec; 6(40):42632-50. PubMed ID: 26536660
[TBL] [Abstract][Full Text] [Related]
5. Tyrosine phosphatase SHP2 regulates the expression of acyl-CoA synthetase ACSL4.
Cooke M; Orlando U; Maloberti P; Podestá EJ; Cornejo Maciel F
J Lipid Res; 2011 Nov; 52(11):1936-48. PubMed ID: 21903867
[TBL] [Abstract][Full Text] [Related]
6. Diminished acyl-CoA synthetase isoform 4 activity in INS 832/13 cells reduces cellular epoxyeicosatrienoic acid levels and results in impaired glucose-stimulated insulin secretion.
Klett EL; Chen S; Edin ML; Li LO; Ilkayeva O; Zeldin DC; Newgard CB; Coleman RA
J Biol Chem; 2013 Jul; 288(30):21618-29. PubMed ID: 23766516
[TBL] [Abstract][Full Text] [Related]
7. Long chain fatty Acyl-CoA synthetase 4 is a biomarker for and mediator of hormone resistance in human breast cancer.
Wu X; Li Y; Wang J; Wen X; Marcus MT; Daniels G; Zhang DY; Ye F; Wang LH; Du X; Adams S; Singh B; Zavadil J; Lee P; Monaco ME
PLoS One; 2013; 8(10):e77060. PubMed ID: 24155918
[TBL] [Abstract][Full Text] [Related]
8. 17β-estradiol-induced ACSL4 protein expression promotes an invasive phenotype in estrogen receptor positive mammary carcinoma cells.
Belkaid A; Ouellette RJ; Surette ME
Carcinogenesis; 2017 Apr; 38(4):402-410. PubMed ID: 28334272
[TBL] [Abstract][Full Text] [Related]
9. Role of long-chain acyl-coenzyme A synthetases in the regulation of arachidonic acid metabolism in interleukin 1β-stimulated rat fibroblasts.
Kuwata H; Yoshimura M; Sasaki Y; Yoda E; Nakatani Y; Kudo I; Hara S
Biochim Biophys Acta; 2014 Jan; 1841(1):44-53. PubMed ID: 24095834
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of long-chain acyl-CoA synthetase 4 facilitates production of 5, 11-dihydroxyeicosatetraenoic acid via the cyclooxygenase-2 pathway.
Kuwata H; Hara S
Biochem Biophys Res Commun; 2015 Sep; 465(3):528-33. PubMed ID: 26282205
[TBL] [Abstract][Full Text] [Related]
11. Role of acyl-CoA synthetase ACSL4 in arachidonic acid metabolism.
Kuwata H; Hara S
Prostaglandins Other Lipid Mediat; 2019 Oct; 144():106363. PubMed ID: 31306767
[TBL] [Abstract][Full Text] [Related]
12. Long-chain acyl-CoA synthetase 4 participates in the formation of highly unsaturated fatty acid-containing phospholipids in murine macrophages.
Kuwata H; Nakatani E; Shimbara-Matsubayashi S; Ishikawa F; Shibanuma M; Sasaki Y; Yoda E; Nakatani Y; Hara S
Biochim Biophys Acta Mol Cell Biol Lipids; 2019 Nov; 1864(11):1606-1618. PubMed ID: 31376475
[TBL] [Abstract][Full Text] [Related]
13. Regulation and role of Acyl-CoA synthetase 4 in glial cells.
Dattilo MA; Benzo Y; Herrera LM; Prada JG; Lopez PF; Caruso CM; Lasaga M; García CI; Paz C; Maloberti PM
J Steroid Biochem Mol Biol; 2021 Apr; 208():105792. PubMed ID: 33246155
[TBL] [Abstract][Full Text] [Related]
14. Tumor-suppressive functions of long-chain acyl-CoA synthetase 4 in gastric cancer.
Ye X; Zhang Y; Wang X; Li Y; Gao Y
IUBMB Life; 2016 Apr; 68(4):320-7. PubMed ID: 26949059
[TBL] [Abstract][Full Text] [Related]
15. Arachidonic acid downregulates acyl-CoA synthetase 4 expression by promoting its ubiquitination and proteasomal degradation.
Kan CF; Singh AB; Stafforini DM; Azhar S; Liu J
J Lipid Res; 2014 Aug; 55(8):1657-67. PubMed ID: 24879802
[TBL] [Abstract][Full Text] [Related]
16. Regulatory mechanisms leading to differential Acyl-CoA synthetase 4 expression in breast cancer cells.
Dattilo MA; Benzo Y; Herrera LM; Prada JG; Castillo AF; Orlando UD; Podesta EJ; Maloberti PM
Sci Rep; 2019 Jul; 9(1):10324. PubMed ID: 31311992
[TBL] [Abstract][Full Text] [Related]
17. Association of long-chain acyl-coenzyme A synthetase 5 expression in human breast cancer by estrogen receptor status and its clinical significance.
Yen MC; Kan JY; Hsieh CJ; Kuo PL; Hou MF; Hsu YL
Oncol Rep; 2017 Jun; 37(6):3253-3260. PubMed ID: 28498416
[TBL] [Abstract][Full Text] [Related]
18. The endogenous subcellular localisations of the long chain fatty acid-activating enzymes ACSL3 and ACSL4 in sarcoma and breast cancer cells.
Radif Y; Ndiaye H; Kalantzi V; Jacobs R; Hall A; Minogue S; Waugh MG
Mol Cell Biochem; 2018 Nov; 448(1-2):275-286. PubMed ID: 29450800
[TBL] [Abstract][Full Text] [Related]
19. Long-chain acyl-CoA synthetase 4 modulates prostaglandin E₂ release from human arterial smooth muscle cells.
Golej DL; Askari B; Kramer F; Barnhart S; Vivekanandan-Giri A; Pennathur S; Bornfeldt KE
J Lipid Res; 2011 Apr; 52(4):782-93. PubMed ID: 21242590
[TBL] [Abstract][Full Text] [Related]
20. Effects of Long-Chain Fatty Acyl-CoA Synthetase 1 on Diglyceride Synthesis and Arachidonic Acid Metabolism in Sheep Adipocytes.
Cao Y; Wang S; Liu S; Wang Y; Jin H; Ma H; Luo X; Cao Y; Lian Z
Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32192050
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]